The finding that ACAT inhibition alleviates disease development in models of both ATH and AD (see earlier) confirms that ACAT-mediated sterol esterification, driven by 25OHC, is a key contributor to disease progression. The gene discussed is ACAT1; the disease is Alzheimer disease.